Ordinarily, in someone who has not lost weight on Ozempic-type drugs, if theres a complication [related to healing] after surgery, we see it as early as week two, and we tend to see good healing between weeks four and six. But for GLP-1 patients, incisions will sometimes reopen in spots
Results of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial, which compared dapagliflozin (10 mg once daily) to placebo, found that dapagliflozin was associated with a 44% reduction in a composite of adverse kidney outcomes and a 29% reduction in death from cardiovascular causes or hospitalization for heart failure
2020 Jan;48:102234
10.1136/bmj-2023-076410 65 YuanC
Abiola JO, Oluyemi AA, Idowu OT, Oyinloye OM, Ubah CS, Owolabi OV, Somade OT, Onikanni SA, Ajiboye BO, Osunsanmi FO, et al